Israel - English - Ministry of Health

organon pharma israel ltd., israel - atorvastatin as calcium trihydrate; ezetimibe - film coated tablets - atorvastatin as calcium trihydrate 10 mg; ezetimibe 10 mg - atorvastatin and ezetimibe - - prevention of cardiovascular eventsatozet is indicated to reduce the risk of cardiovascular events in patients with coronary heart disease (chd) and a history of acute coronary syndrome (acs), either previously treated with a statin or not.- hypercholesterolaemiaatozet is indicated as adjunctive therapy to diet for use in adults with primary (heterozygous familial and non-familial) hypercholesterolaemia or mixed hyperlipidaemia where use of a combination product is appropriate• patients not appropriately controlled with a statin alone• patients already treated with a statin and ezetimibe- homozygous familial hypercholesterolaemia (hofh)atozet is indicated as adjunctive therapy to diet for use in adults with hofh. patients may also receive adjunctive treatments (e.g., low-density lipoprotein [ldl] apheresis).

Israel - English - Ministry of Health

organon pharma israel ltd., israel - atorvastatin as calcium trihydrate; ezetimibe - film coated tablets - atorvastatin as calcium trihydrate 20 mg; ezetimibe 10 mg - atorvastatin and ezetimibe - - prevention of cardiovascular eventsatozet is indicated to reduce the risk of cardiovascular events in patients with coronary heart disease (chd) and a history of acute coronary syndrome (acs), either previously treated with a statin or not.- hypercholesterolaemiaatozet is indicated as adjunctive therapy to diet for use in adults with primary (heterozygous familial and non-familial) hypercholesterolaemia or mixed hyperlipidaemia where use of a combination product is appropriate• patients not appropriately controlled with a statin alone• patients already treated with a statin and ezetimibe- homozygous familial hypercholesterolaemia (hofh)atozet is indicated as adjunctive therapy to diet for use in adults with hofh. patients may also receive adjunctive treatments (e.g., low-density lipoprotein [ldl] apheresis).

Israel - English - Ministry of Health

organon pharma israel ltd., israel - atorvastatin as calcium trihydrate; ezetimibe - film coated tablets - atorvastatin as calcium trihydrate 40 mg; ezetimibe 10 mg - atorvastatin and ezetimibe - - prevention of cardiovascular eventsatozet is indicated to reduce the risk of cardiovascular events in patients with coronary heart disease (chd) and a history of acute coronary syndrome (acs), either previously treated with a statin or not.- hypercholesterolaemiaatozet is indicated as adjunctive therapy to diet for use in adults with primary (heterozygous familial and non-familial) hypercholesterolaemia or mixed hyperlipidaemia where use of a combination product is appropriate• patients not appropriately controlled with a statin alone• patients already treated with a statin and ezetimibe- homozygous familial hypercholesterolaemia (hofh)atozet is indicated as adjunctive therapy to diet for use in adults with hofh. patients may also receive adjunctive treatments (e.g., low-density lipoprotein [ldl] apheresis).

Israel - English - Ministry of Health

organon pharma israel ltd., israel - atorvastatin as calcium trihydrate; ezetimibe - film coated tablets - atorvastatin as calcium trihydrate 80 mg; ezetimibe 10 mg - atorvastatin and ezetimibe - - prevention of cardiovascular eventsatozet is indicated to reduce the risk of cardiovascular events in patients with coronary heart disease (chd) and a history of acute coronary syndrome (acs), either previously treated with a statin or not.- hypercholesterolaemiaatozet is indicated as adjunctive therapy to diet for use in adults with primary (heterozygous familial and non-familial) hypercholesterolaemia or mixed hyperlipidaemia where use of a combination product is appropriate• patients not appropriately controlled with a statin alone• patients already treated with a statin and ezetimibe- homozygous familial hypercholesterolaemia (hofh)atozet is indicated as adjunctive therapy to diet for use in adults with hofh. patients may also receive adjunctive treatments (e.g., low-density lipoprotein [ldl] apheresis).

Ireland - English - HPRA (Health Products Regulatory Authority)

clonmel healthcare ltd - darunavir - film coated tablet - 400 milligram - protease inhibitors

New Zealand - English - Medsafe (Medicines Safety Authority)

viatris limited - lopinavir 100mg; ritonavir 25mg;   - film coated tablet - 100mg/25mg - active: lopinavir 100mg ritonavir 25mg   excipient: colloidal silicon dioxide copovidone opadry white 20c580015 sodium stearyl fumarate sorbitan laurate - lopinavir/ritonavir mylan is indicated for the treatment of hiv-1 infection, in combination with other antiretroviral agents in adults and children aged 2 years and older.

New Zealand - English - Medsafe (Medicines Safety Authority)

viatris limited - lopinavir 200mg; ritonavir 50mg;   - film coated tablet - 200mg/50mg - active: lopinavir 200mg ritonavir 50mg   excipient: colloidal silicon dioxide copovidone opadry white 20c580015 sodium stearyl fumarate sorbitan laurate - lopinavir/ritonavir mylan is indicated for the treatment of hiv-1 infection, in combination with other antiretroviral agents in adults and children aged 2 years and older.

United States - English - NLM (National Library of Medicine)

avera mckennan hospital - efavirenz (unii: je6h2o27p8) (efavirenz - unii:je6h2o27p8) - efavirenz 600 mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

bristol-myers squibb pharmaceuticals ltd - atazanavir sulfate - capsule - 150mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

bristol-myers squibb pharmaceuticals ltd - atazanavir sulfate - capsule - 200mg